Brief: 23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration
20/11/2024 12:43
Nov 20 (Reuters) - 23andMe Holding Co. ME.O :
* 23ANDME AND MIRADOR THERAPEUTICS ENTER INTO STRATEGIC
RESEARCH
COLLABORATION TO ADVANCE MIRADOR’S PRECISION MEDICINES FOR
IMMUNOLOGY & INFLAMMATION
Source text: ID:nGNXblwb6P
Further company coverage: ME.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chrome Holding Co
See all newsBrief: Chrome Holding Co Enters Into Stock Purchase Agreement With Bambu Ventures
23andMe seeks approval of larger, $50 million data breach settlement
Brief: 23andMe Holding Co Changes Name to Chrome Holding Co
Brief: 23andMe Holding Says Debtors Repay All Outstanding Indebtedness, Terminate Loan Agreement
founder